You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 254 No. 14, October 11, 1985 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Do Oral Contraceptives Prevent Rheumatoid Arthritis?

Deborah J. del Junco, MS; John F. Annegers, PhD; Harvinder S. Luthra, MD; Carolyn B. Coulam, MD; Leonard T. Kurland, MD, DPH

JAMA. 1985;254(14):1938-1941.


Abstract

Two studies have suggested that the risk of rheumatoid arthritis in women using oral contraceptives is less than half that of nonusers. When a third study from the Mayo Clinic failed to confirm these findings, it was criticized for inclusion of ineligible subjects, misclassification of oral contraceptive use, and inadequate statistical power. Recent expansion of the Mayo Clinic's data resources provided a unique opportunity to resolve the controversy, and a new population-based case-control study was undertaken. In comparison with the previous study, the new investigation had 2.2 times as many eligible cases and more complete ascertainment of oral contraceptive use via access to the records of Planned Parenthood of Minnesota. Comparing any prior use of oral contraceptives with never having used them, the relative risk of rheumatoid arthritis estimated from 182 cases and their 182 matched controls was 1.1 (95% confidence interval, 0.7 to 1.7). The relative risk for current use was 1.3 (95% confidence interval, 0.7 to 2.4). The lack of a protective effect was independent of age, disease severity, and disease end point (date of confirmed diagnosis or symptom onset).

(JAMA 1985;254:1938-1941)



Author Affiliations

From the Department of Epidemiology, University of Texas School of Public Health, Houston (Ms del Junco and Dr Annegers); and the Departments of Rheumatology (Dr Luthra), Obstetrics and Gynecology (Dr Coulam), and Epidemiology (Dr Kurland), Mayo Clinic, Rochester, Minn.


Footnotes

Reprint requests to University of Texas School of Public Health, PO Box 20186, Houston, TX 77225 (Ms del Junco).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The Complex Role of Estrogens in Inflammation
Straub
Endocr. Rev. 2007;28:521-574.
ABSTRACT | FULL TEXT  

Early inflammatory polyarthritis: results from the Norfolk Arthritis Register with a review of the literature. I. Risk factors for the development of inflammatory polyarthritis and rheumatoid arthritis
Symmons and Harrison
Rheumatology (Oxford) 2000;39:835-843.
FULL TEXT  

Do Oral Contraceptives Prevent Rheumatoid Arthritis?
Hazes and Dijkmans
JAMA 1986;256:215-215.
ABSTRACT  

Noncontraceptive Hormones and Rheumatoid Arthritis in Perimenopausal and Postmenopausal Women
Vandenbroucke et al.
JAMA 1986;255:1299-1303.
ABSTRACT  

Reversible Contraception for the 1980s
Grimes
JAMA 1986;255:69-75.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1985 American Medical Association. All Rights Reserved.